Aspida Life Sciences Private Limited
Indian Pharmaceutical Exporter ยท Antiviral & HIV Medications Specialist ยท $366.6K Total Trade ยท DGFT Verified
Aspida Life Sciences Private Limited is an Indian pharmaceutical exporter with a total trade value of $366.6K across 3 products in 2 therapeutic categories. Based on 81 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Sofosbuvir ($181.5K), Velpatasvir ($146.1K), Gefitinib ($39.0K).
Aspida Life Sciences Private Limited โ Export Portfolio & Destination Treemap

Who is Aspida Life Sciences Private Limited? โ Company Overview & Market Position
Aspida Life Sciences Private Limited is a privately held pharmaceutical company incorporated on October 23, 2020, in New Delhi, India. The company is registered under the Corporate Identification Number (CIN) U24304DL2020PTC372058. Its authorized and paid-up capital stands at โน1.5 million each. The registered office is located at B-392, Upper Ground Floor, Nirman Vihar, New Delhi, Delhi 110092.
The company's primary focus is on the export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. In the fiscal year 2022-2023, Aspida Life Sciences reported a total export value of $367,000 USD, encompassing 81 shipments across three products in two therapeutic categories. The top three products exported were Sofosbuvir ($182,000), Velpatasvir ($146,000), and Gefitinib ($39,000). The portfolio is heavily concentrated, with the top five products accounting for 100% of the export value.